FDA warns of vision loss risk linked to popular GLP-1 drugs like Wegovy, Zepbound

FDA warns of vision loss risk linked to popular GLP-1 drugs like Wegovy, Zepbound

来源:CNBC发布于 2026-11-10

The FDA is requiring the makers of all GLP-1 medications to add a warning about the potential increased risk of NAION. NAION is a rare condition caused by decreased blood flow to the front part of the...

相关标的:LLYNVO

本文内容来自外部来源,点击「继续访问」将跳转到原始发布站点。